Cargando…

Long-term efficacy and safety of iloperidone: an update

Schizophrenia is a devastating neuropsychiatric disease with a worldwide prevalence of approximately 0.5%–1%. Since many patients do not achieve adequate symptom relief from available agents, alternate pharmacotherapeutic approaches are needed. In this context, iloperidone was recently approved by t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rado, Jeffrey T, Janicak, Philip G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3942304/ https://www.ncbi.nlm.nih.gov/pubmed/24600226 http://dx.doi.org/10.2147/NDT.S37824

Ejemplares similares

Aripiprazole for late-life schizophrenia
por: Rado, Jeffrey, et al.
Publicado: (2010)

New atypical antipsychotics for schizophrenia: iloperidone
por: Caccia, Silvio, et al.
Publicado: (2010)

Ventricular premature contractions associated with iloperidone
por: Achalia, Rashmin, et al.
Publicado: (2013)

Iloperidone-induced Galactorrhea in a Middle-aged Female
por: Dutta, Arghya, et al.
Publicado: (2012)

Iloperidone-induced ejaculatory dysfunction: A case series
por: Ravani, Niraj Narendra, et al.
Publicado: (2016)

A Randomized Trial of Iloperidone for Prevention of Relapse in Schizophrenia: The REPRIEVE Study
por: Weiden, Peter J., et al.
Publicado: (2016)

Iloperidone in the treatment of schizophrenia: an evidence-based review of its place in therapy
por: Tonin, Fernanda S, et al.
Publicado: (2016)

A case of iloperidone overdose in a 27-year-old man with cocaine abuse
por: Amon, Jin, et al.
Publicado: (2016)

Synthesis and Characterization of Carbon-11 Labeled Iloperidone for Imaging of α(1)-Adrenoceptor in Brain
por: Xu, Yulong, et al.
Publicado: (2020)

Metabolic Side-Effects of the Novel Second-Generation Antipsychotic Drugs Asenapine and Iloperidone: A Comparison with Olanzapine
por: Boyda, Heidi N., et al.
Publicado: (2013)

Applied statistics in occupational safety and health
por: Janicak, Christopher A
Publicado: (2017)

Sex-Specific Cannabidiol- and Iloperidone-Induced Neuronal Activity Changes in an In Vitro MAM Model System of Schizophrenia
por: Thériault, Rachel-Karson, et al.
Publicado: (2021)

Long-Term Treatment with Atypical Antipsychotic Iloperidone Modulates Cytochrome P450 2D (CYP2D) Expression and Activity in the Liver and Brain via Different Mechanisms
por: Danek, Przemysław J., et al.
Publicado: (2021)

Anti-Obesity Drugs: Long-Term Efficacy and Safety: An Updated Review
por: Tak, Young Jin, et al.
Publicado: (2021)

The Effect of Chronic Iloperidone Treatment on Cytochrome P450 Expression and Activity in the Rat Liver: Involvement of Neuroendocrine Mechanisms
por: Danek, Przemysław J., et al.
Publicado: (2021)

The atypical neuroleptics iloperidone and lurasidone inhibit human cytochrome P450 enzymes in vitro. Evaluation of potential metabolic interactions
por: Danek, Przemysław J., et al.
Publicado: (2020)

Long-term safety and efficacy of raloxifene in the prevention and treatment of postmenopausal osteoporosis: an update
por: Messalli, Enrico M, et al.
Publicado: (2010)

Paliperidone ER: a review of the clinical trial data
por: Janicak, Philip G, et al.
Publicado: (2007)

Transcranial magnetic stimulation for the treatment of major depression
por: Janicak, Philip G, et al.
Publicado: (2015)

PM431. Effects of iloperidon and nemonaprid on depression, anxiety-like behaviour and locomotion: Altered gen expression levels of FGF2, synapsin and NGF in the hippocampus of mice
por: Mutlu, Oguz, et al.
Publicado: (2016)

Long‐term efficacy and safety of dichlorphenamide for treatment of primary periodic paralysis
por: Sansone, Valeria A., et al.
Publicado: (2021)

Biologics in Psoriasis: Updated Perspectives on Long-Term Safety and Risk Management
por: Al-Janabi, A, et al.
Publicado: (2022)

Long-term Efficacy and Safety of Adalimumab in Pediatric Patients with Crohn's Disease
por: Faubion, William A., et al.
Publicado: (2017)

Long-term efficacy and safety of human papillomavirus vaccination
por: De Vincenzo, Rosa, et al.
Publicado: (2014)

Long-term efficacy and safety of biologics in rheumatoid arthritis
por: Montecucco, Carlomaurizio
Publicado: (2012)

Deferasirox: appraisal of safety and efficacy in long-term therapy
por: Chaudhary, Preeti, et al.
Publicado: (2013)

Long-term efficacy, safety and durability of Juvéderm® XC
por: Ballin, Annelyse C, et al.
Publicado: (2013)

Testosterone Replacement Therapy: Long-Term Safety and Efficacy
por: Corona, Giovanni, et al.
Publicado: (2017)

Long-Term Safety and Efficacy of Tacrolimus in Myasthenia Gravis
por: Kim, Yool-hee, et al.
Publicado: (2019)

Biologics in Psoriasis: Updated Perspectives on Long-Term Safety and Risk Management [Corrigendum]
Publicado: (2022)

Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study
por: Sekulic, Aleksandar, et al.
Publicado: (2017)

Long-term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: NEURO-TTR open-label extension 3-year update
por: Brannagan, Thomas H., et al.
Publicado: (2022)

Long-term safety and efficacy of deutetrabenazine for the treatment of tardive dyskinesia
por: Fernandez, Hubert H, et al.
Publicado: (2019)

Hypofractionated Stereotactic Radiotherapy for the Treatment of Benign Intracranial Meningiomas: Long-Term Safety and Efficacy
por: Nguyen, Eric K., et al.
Publicado: (2021)

Correction to: Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study
por: Sekulic, Aleksandar, et al.
Publicado: (2019)

Long-term safety and efficacy of budesonide in the treatment of ulcerative colitis
por: Iborra, Marisa, et al.
Publicado: (2014)

Long-term efficacy and safety of raltegravir in the management of HIV infection
por: Liedtke, Michelle D, et al.
Publicado: (2014)

The long-term efficacy and safety of new biological therapies for psoriasis
por: Papp, Kim A.
Publicado: (2006)

Long-Term Efficacy and Safety of Zonisamide Monotherapy in Epilepsy Patients
por: Park, Sung-Pa, et al.
Publicado: (2007)

Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumab
por: Anastasilakis, Athanasios D, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_gvj4a5iql3oc6sp48g01ijqof8